[Spontaneous intraparenchymatous hematomas. Experience with 134 cases]

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Context:

• Spontaneous intraparenchymal hematomas (SIPH) represent a significant cause of neurological morbidity and mortality.
• Understanding factors influencing SIPH outcomes is crucial for effective clinical management.
• Treatment strategies for SIPH vary, necessitating research into their comparative effectiveness.

Purpose:

• To analyze the relationship between patient characteristics, hematoma features, and treatment protocols on mortality in spontaneous intraparenchymal hematomas.
• To identify specific risk factors associated with increased mortality in SIPH cases.
• To evaluate the outcomes of different treatment approaches for SIPH.

Summary:

• This study investigated 134 cases of spontaneous intraparenchymal hematomas, categorizing them into six groups based on topography, consciousness level, and volume.
• Patients received varied treatment protocols, including conservative management, ICP monitoring, and surgical intervention.
• Increased mortality was observed in patients with severely compromised consciousness, those over 50, and those with hematomas in specific locations (quadrilateral, intraventricular, brainstem).
• The overall mortality rate in the studied cohort was 26.1%.

Impact:

• Findings highlight critical prognostic indicators for spontaneous intraparenchymal hematomas, aiding in risk stratification.
• Identifies patient subgroups (e.g., elderly, severely impaired consciousness) and hematoma characteristics (e.g., specific locations, large volumes) associated with poorer prognoses.
• Informs clinical decision-making regarding treatment intensity and resource allocation for patients with spontaneous intraparenchymal hematomas.